A detailed history of Atlas Private Wealth Management transactions in Abb Vie Inc. stock. As of the latest transaction made, Atlas Private Wealth Management holds 5,512 shares of ABBV stock, worth $975,348. This represents 0.44% of its overall portfolio holdings.

Number of Shares
5,512
Previous 5,675 2.87%
Holding current value
$975,348
Previous $879,000 14.11%
% of portfolio
0.44%
Previous 0.43%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 15, 2024

SELL
$159.82 - $182.1 $26,050 - $29,682
-163 Reduced 2.87%
5,512 $1 Million
Q4 2023

Jan 19, 2024

BUY
$137.6 - $154.97 $550 - $619
4 Added 0.07%
5,675 $879,000
Q3 2023

Oct 23, 2023

SELL
$133.59 - $154.65 $6,278 - $7,268
-47 Reduced 0.82%
5,671 $845,000
Q2 2023

Jul 13, 2023

SELL
$132.51 - $164.9 $16,696 - $20,777
-126 Reduced 2.16%
5,718 $770,000
Q1 2023

Apr 26, 2023

BUY
$144.61 - $166.54 $8,387 - $9,659
58 Added 1.0%
5,844 $931,000
Q4 2022

Jan 18, 2023

SELL
$138.31 - $165.87 $968 - $1,161
-7 Reduced 0.12%
5,786 $0
Q3 2022

Oct 26, 2022

BUY
$134.21 - $153.93 $268 - $307
2 Added 0.03%
5,793 $778,000
Q2 2022

Jul 19, 2022

SELL
$137.62 - $174.96 $13,349 - $16,971
-97 Reduced 1.65%
5,791 $887,000
Q1 2022

Apr 25, 2022

BUY
$131.98 - $163.75 $61,502 - $76,307
466 Added 8.59%
5,888 $954,000
Q4 2021

Feb 07, 2022

BUY
$107.43 - $135.93 $322 - $407
3 Added 0.06%
5,422 $734,000
Q3 2021

Oct 25, 2021

SELL
$106.4 - $120.78 $40,112 - $45,534
-377 Reduced 6.5%
5,419 $585,000
Q2 2021

Aug 05, 2021

SELL
$105.21 - $117.21 $30,405 - $33,873
-289 Reduced 4.75%
5,796 $653,000
Q1 2021

Apr 26, 2021

SELL
$102.3 - $112.62 $61,993 - $68,247
-606 Reduced 9.06%
6,085 $658,000
Q4 2020

Jan 27, 2021

SELL
$80.49 - $108.67 $53,525 - $72,265
-665 Reduced 9.04%
6,691 $717,000
Q3 2020

Nov 05, 2020

SELL
$85.91 - $100.83 $102,834 - $120,693
-1,197 Reduced 14.0%
7,356 $644,000
Q2 2020

Aug 04, 2020

BUY
$73.37 - $98.18 $293 - $392
4 Added 0.05%
8,553 $840,000
Q1 2020

May 12, 2020

SELL
$64.5 - $97.79 $387 - $586
-6 Reduced 0.07%
8,549 $651,000
Q4 2019

Feb 11, 2020

BUY
$72.13 - $90.25 $617,072 - $772,088
8,555 New
8,555 $758,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $313B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Atlas Private Wealth Management Portfolio

Follow Atlas Private Wealth Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Atlas Private Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Atlas Private Wealth Management with notifications on news.